Pharmaceutical products

Contract Value:: -
Notice Type:: Contract Notice

Published Date:: 12 September 2023
Closing Date:: 17 October 2023

Location(s):: PL91 Warszawski stołeczny (PL Poland/POLSKA); PL911 Miasto Warszawa (PL Poland/POLSKA)

Description:

Successive supply of medicinal products and foodstuffs for special medical purposes

The subject of the contract is the successive delivery of medicinal products and foodstuffs for special medical purposes.

Bupivacaine

Part I - BUPIVACAINE - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

ANTITHROMBIN III

Part X - ANTITHROMBIN III - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

Phosphomycin

Part XI - FOSFOMYCIN - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

PLASMA PROTEINS

Part XII - PLASMA PROTEINS - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

INSULIN

Part XIII - INSULIN- Requirements and a detailed description of the subject of the contract are specified in the annexes to the SWZ

Oral diet

Part XIV - ORAL DIET - Requirements and detailed description of the subject of the contract are specified in the annexes to the CMS

PEPTIDE DIET

Part XV - PEPTIDE DIET - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

INCLISIRAN – program lekowy

Part XVI - INCLISIRAN - drug program - The requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

VALGANCICLOVIR

Part XVII - VALGANCICLOVIR - Requirements and a detailed description of the subject of the contract are specified in the annexes to the SWZ

Paraffinum liquidum

Part XVIII - PARAFFINUM LIQUIDUM - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

Bivalirudin

Part XIX- BIVALIRUDIN - Requirements and a detailed description of the subject of the contract are specified in the annexes to the SWZ

Betahistine

Part II- BETAHISTINE - Requirements and detailed description of the subject of the contract are specified in the annexes to the CMS

Voriconazoles

Part XX - VORICONAZOLE - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

GANCICLOVIR

Part III - GANCICLOVIR - Requirements and a detailed description of the subject of the contract are specified in the annexes to the SWZ

Landiolol

Part IV - LANDIOLOL - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

ALBUMIN I

Part V - ALBUMIN I - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

ALBUMIN II

Part VI - ALBUMIN II - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

Sevoflurane

Part VII - SEVOFLURANE - Requirements and a detailed description of the subject of the contract are specified in the annexes to the SWZ

Epoetin alpha

Part VIII - EPOETIN ALFA - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

thiopental

Part IX - THIOPENTAL - Requirements and detailed description of the subject of the contract are specified in the annexes to the SWZ

: Download full details as .pdf

The Buyer:: Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy

CPV Code(s):: 33600000 - Pharmaceutical products; 33690000 - Various medicinal products; 33692510 - Intravenous fluids